IBI363 + Chemotherapy Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer
IBI363 + Chemotherapy
Zhejiang Cancer Hospital60 enrolled1 locationNCT07325630
Recruiting
Phase 1
Study of IBI363 in Patients with Advanced First-line Gastric Cancer
IBI363 + Chemotherapy
Xiangdong Cheng40 enrolled1 locationNCT06610799